NCT02804334View on ClinicalTrials.gov

The Role of Molecules in Blood Cells for Diagnosing Bipolar Disorders

TerminatedOBSERVATIONAL

Enrollment

29

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

October 31, 2018

Study Completion Date

October 31, 2018

Conditions

Bipolar Disorder

Interventions

PROCEDURE

Psychiatric Questionnaires

PROCEDURE

Blood draw

Trial Locations (1)

44106

University Hospitals Cleveland Medical Center, Cleveland

Sponsors

Collaborators (1)

CellPrint Biotechnology

All Listed Sponsors

collaborator

CellPrint Biotechnology

OTHER

lead

University Hospitals Cleveland Medical Center

OTHER